Skip to content

UK becomes first to authorize Merck and Ridgeback Biotherapeutics’ antiviral molnupiravir to treat mild-to-moderate Covid-19 – CNN

UK becomes first to authorize Merck and Ridgeback Biotherapeutics’ antiviral molnupiravir to treat mild-to-moderate Covid-19  CNNUK authorizes Merck antiviral pill, 1st shown to treat COVID  Yahoo NewsEngland’s No. 2 doctor warns of ‘hard months to come in the winter’ from COVID  NPRFirst pill to treat Covid gets approval in UK  BBC NewsBritain approves Merck’s COVID-19 pill in world first  Yahoo News

Leave a Reply

Your email address will not be published. Required fields are marked *